TY - JOUR
T1 - Reduced Long-Term Survival After Postoperative Complications in Major Gastrointestinal Surgery
AU - Gratama, Daantje N.
AU - Weinberg, Laurence
AU - Raykateeraroj, Nattaya
AU - Suh, Je Min A.
AU - Zhao, Junyan
AU - Hu, Elizabeth P.
AU - Ratnasekara, Vidhura
AU - Freeman, Thomas
AU - Liu, David S.
AU - Joosten, Alexandre
AU - Muralidharan, Vijayaragavan
AU - Nikfarjam, Mehrdad
AU - Lee, Dong Kyu
N1 - Publisher Copyright:
© 2025 Gratama et al.
PY - 2025
Y1 - 2025
N2 - Purpose: We primarily evaluated the relationship between postoperative complications and long-term survival in patients undergoing major gastrointestinal surgery. Secondarily, we investigated the relationship between the severity and the number of complications and long-term survival. While postoperative complications are prevalent after major abdominal surgery and associated with increased mortality, the effect of their severity and accumulation remains insufficiently explored. Patients and Methods: 1989 adult patients undergoing major gastrointestinal surgery between July 2010 and April 2022 were retrospectively studied. Complications were classified using the Clavien-Dindo system. Kaplan-Meier analysis assessed long-term survival, Cox proportional hazards regression with time-dependent coefficients evaluated the impact of complications on mortality. Results: Median age was 64 years (IQR 53–74); 41.8% female and 63.0% of patients were diagnosed with malignancy. Elective procedures comprised 73.0% of cases. Complications occurred in 74.6% of patients. Mortality was higher in patients with complications (32.0%, 95% CI 29.7%-34.5%), compared to those without (21.7%, 95% CI 18.3–25.6%; P<0.001). Severe complications (Clavien-Dindo Grade ≥III) were associated with a 15.01-fold higher hazard of mortality within 18 months postoperatively (95% CI 6.83–33.0; P<0.001). Conclusion: Postoperative complications significantly reduce long-term survival following major gastrointestinal surgery. Both their severity and frequency are critical determinants of poorer outcomes, emphasizing the need for effective prevention strategies.
AB - Purpose: We primarily evaluated the relationship between postoperative complications and long-term survival in patients undergoing major gastrointestinal surgery. Secondarily, we investigated the relationship between the severity and the number of complications and long-term survival. While postoperative complications are prevalent after major abdominal surgery and associated with increased mortality, the effect of their severity and accumulation remains insufficiently explored. Patients and Methods: 1989 adult patients undergoing major gastrointestinal surgery between July 2010 and April 2022 were retrospectively studied. Complications were classified using the Clavien-Dindo system. Kaplan-Meier analysis assessed long-term survival, Cox proportional hazards regression with time-dependent coefficients evaluated the impact of complications on mortality. Results: Median age was 64 years (IQR 53–74); 41.8% female and 63.0% of patients were diagnosed with malignancy. Elective procedures comprised 73.0% of cases. Complications occurred in 74.6% of patients. Mortality was higher in patients with complications (32.0%, 95% CI 29.7%-34.5%), compared to those without (21.7%, 95% CI 18.3–25.6%; P<0.001). Severe complications (Clavien-Dindo Grade ≥III) were associated with a 15.01-fold higher hazard of mortality within 18 months postoperatively (95% CI 6.83–33.0; P<0.001). Conclusion: Postoperative complications significantly reduce long-term survival following major gastrointestinal surgery. Both their severity and frequency are critical determinants of poorer outcomes, emphasizing the need for effective prevention strategies.
KW - Clavien-Dindo classification
KW - Kaplan-Meier
KW - long-term mortality
KW - mortality risk factors
KW - surgical outcomes
KW - survival analysis
UR - https://www.scopus.com/pages/publications/105018788379
U2 - 10.2147/TCRM.S543913
DO - 10.2147/TCRM.S543913
M3 - Article
AN - SCOPUS:105018788379
SN - 1176-6336
VL - 21
SP - 1459
EP - 1472
JO - Therapeutics and Clinical Risk Management
JF - Therapeutics and Clinical Risk Management
ER -